These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22074933)

  • 21. Varicella-zoster virus: Prevention through vaccination.
    Gnann JW
    Clin Obstet Gynecol; 2012 Jun; 55(2):560-70. PubMed ID: 22510639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
    Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
    Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunity to varicella zoster virus in young Israeli adults.
    Avrahami-Heller Y; Cohen D; Orr N; Slepon R; Ashkenazi I; Danon YL
    Isr Med Assoc J; 2000 Mar; 2(3):196-9. PubMed ID: 10774265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
    Reynolds MA; Chaves SS; Harpaz R; Lopez AS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S224-7. PubMed ID: 18419401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevalence of varicella zoster virus in pregnant patients].
    Sauerbrei A; Sonntag S; Wutzler P
    Zentralbl Gynakol; 1990; 112(4):223-6. PubMed ID: 2159681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility to varicella-zoster virus in Thai children and young adults.
    Kositanont U; Wasi C; Oonsombat P; Suvatte V; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):414-20. PubMed ID: 3006266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan.
    Chang CK; Tan HF; Tseng HF; Lin CC
    Med Mal Infect; 2007 Apr; 37(4):222-8. PubMed ID: 17368781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
    Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
    Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
    Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
    Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changing seroprevalence of varicella zoster virus infection in a tropical city state, Singapore.
    Fatha N; Ang LW; Goh KT
    Int J Infect Dis; 2014 May; 22():73-7. PubMed ID: 24269652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test.
    Enders G
    Postgrad Med J; 1985; 61 Suppl 4():23-30. PubMed ID: 3014475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varicella-zoster virus immunity among health care workers in Catalonia.
    Urbiztondo L; Bayas JM; Broner S; Costa J; Esteve M; Campins M; Borrás E; Domínguez A;
    Vaccine; 2014 Oct; 32(45):5945-8. PubMed ID: 25219564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroepidemiology of varicella-zoster in Pakistan.
    Akram DS; Qureshi H; Mahmud A; Khan AA; Kundi Z; Shafi S; N-ur-Rehman ; Olowokure B; Weil J; Bock H; Yazdani I
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):646-9. PubMed ID: 11414405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infectious immune status in an obstetric population of Pakistani immigrants in Norway.
    Bjerke SE; Vangen S; Holter E; Stray-Pedersen B
    Scand J Public Health; 2011 Jul; 39(5):464-70. PubMed ID: 21339369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varicella: a vaccine preventable disease?
    Watson B
    J Infect; 2002 May; 44(4):220-5. PubMed ID: 12099727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
    Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
    J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.